Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Registration opens for RNAi and High Content Imaging 2011

Published: Tuesday, February 08, 2011
Last Updated: Tuesday, February 08, 2011
Bookmark and Share
Molecular Devices Inc. announces that they have opened registration for its RNAi & High Content Imaging Symposium 2011, to be held at the Oxford Spires Four Pillars, Oxford on 1st April 2011.

The meeting has been structured to reflect the significant role that RNAi and High Content Imaging has in the market and to address these areas we are bringing together the leading experts in industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace.

“Molecular Devices’ imaging symposium is growing in stature each year as a major highlight in the imaging research calendar”, explains Richard Patterson, European Drug Discovery Director. “Visitors appreciate the unique opportunity this symposium provides to meet and network with researchers in a comfortable environment that is conducive to learning about new applications in High Content Screening.”

Join influential and respected scientists to discuss the expansion of RNAi profiling techniques and how to enhance gene expression assays using high content imaging systems. The preliminary agenda includes presentations by:

•    Session Chair: Dr. Anthony Davies, Trinity College Dublin
•    Dr. Peter Horvath, Light Microscopy Centre, ETH Zurich
•    Dr. Stephen Brown, University of Sheffield
•    Dr. Olivier Pardo, Imperial College London
•    Dr. Karol Kozak, LMC-RISC, Institute for Biochemistry, ETH Zurich
•    Dr. Christoph Kasper and Dr. Mario Emmenlauer, Biozentrum Basel
•    Dr. Ross Paveley, London School Of Hygiene Tropical Medicine,
•    Dr. Ami Ketley, University of Nottingham
•    Dr. Miguel Mano, iRNA HTS Screening facility, International Centre for Genetic Engineering and Biotechnology (ICGEB)

Additional user-presentations will focus on RNAi profiling techniques, tips and tricks for interrogating large-scale RNAi libraries as well as automated data analysis and integration. Do not miss this opportunity to join your industry colleagues…

Registration for this event is free of charge. Attendance will be limited, so please register early for this event at http://imagingsymposium2011.eventbrite.com, a new dedicated web site focused exclusively on Molecular Devices symposiums.

Refreshments and a buffet lunch will be served during the symposium.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors
The new Board will support the Company’s strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer.
Wednesday, February 29, 2012
Molecular Devices’ RNAi and High Content Imaging Symposium
The RNAi and High Content Imaging Symposium will be discussed at a one day symposium to be held at The Burlington Hotel, Dublin, Ireland, September 16, 2010. The symposium follows the RNAi & miRNA Europe Conference.
Tuesday, September 14, 2010
Scientific News
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Cancer Cells Coordinate to Form Roving Clusters
Rice University scientists identify ‘smoking gun’ in metastasis of hybrid cells.
Poliovirus Therapy Wins 'Breakthrough' Status
FDA decision will fast-track research on breakthrough Duke brain cancer therapy.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!